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Self-reported estimation of usual walking speed
improves the performance of questionnaires
estimating walking capacity in patients with
vascular-type claudication
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Angers, France
Objective: Most questionnaires do not estimate the usual walking speed of the patient, although it is well known that
patients may experience apparently different walking capacities if walking slow or fast. We hypothesized that correcting
the self-reported estimated walking capacity by a coefficient issued from the self-reported estimation of usual walking
speed would significantly improve the correlation between questionnaire-estimated and treadmill-measured walking
capacity.
Methods: Three hundred ten consecutive patients complaining of vascular-type claudication were asked to estimate their
usual walking speed in comparison to people of their age (or friends or relatives) with ratings ranging from much slower
(1 pt) to much faster (5 pts), in addition to the filling out of the walking impairment questionnaire (WIQ) and the
estimated ambulatory capacity by history questionnaire (EACH-Q). Corrected WIQ (WIQc) and corrected EACH-Q
(EACH-Qc) scores were obtained by multiplying the scores of each questionnaire by the “usual-speed” coefficient and
dividing by 5. Results for questionnaire scores were compared to maximal walking time (MWT) on a treadmill.
Results: All but four patients self-completed the usual-speed question. Median scores (25-75 centiles) were 41% (26-59)
for the WIQ and 24% (11-41) for the EACH-Q. Coefficients of correlation of the three WIQ subscales and of the
EACH-Qwith treadmill results were significantly improved after correction by the “usual-speed” question. Overall, WIQ
(mean of the three WIQ subscales) tended to improve but did not reach significance.
Conclusion: Correcting the self-reported estimation of walking capacity by a self-reported estimation of usual walking
pace significantly improves the correlation of all WIQ subscale scores and of the EACH-Q score with treadmill
measurements of capacity. This confirms the interest of speed estimation in patients with peripheral arterial occlusive
disease and claudication. (J Vasc Surg 2011;54:1360-5.)
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dLimitation of walking capacity is frequent in elderly
patients and is observed in various diseases such lumbar
spine stenosis, heart failure, hip or knee arthritis, or periph-
eral arterial occlusive disease (PAOD). In typical vascular-
type claudication,1 pain is absent at rest, occurs after a
certain distance at exercise, and forces the person to slow
down or stop. The time or distance that can be performed
without slowing down or stopping, grades the severity of the
disease. Treadmill testing is a gold standard for estimating
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1360alking ability2 but is not accessible to all physicians. Estima-
ion of walking capacity by history is easy and readily accessible
o the clinician. In order to standardize patient’s self-reports,
uestionnaires are largely used.3-13 One point of interest is
hat most questionnaires do not estimate the usual walking
peed of the patient, although it is well known that patients
ay experience apparently different walking capacities if
alking slow or fast.14,15 Then, discordant results between
elf-reported and measured walking capacity might partly
ely on differences in individual usual walking speed. We
ypothesized that correcting the self-reported estimated
alking capacity by a coefficient issued from the self-
eported estimation of usual walking speed would signifi-
antly improve the correlation between questionnaire-
stimated and treadmill-measured walking capacity.
ETHODS
Study population. A prospective study was per-
ormed on all new patients referred for treadmill testing to
ur laboratory and that fulfilled vascular-type claudication
riteria (as such suspected of vascular origin). Vascular-type
laudication is defined as the occurrence of limb pain or
iscomfort while walking that forces the patient to slow
own or stop and recovers within 10 minutes after walking
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Volume 54, Number 5 Mahe et al 1361is stopped.2 We analyzed the correlation of walking capac-
ity estimated by the “Walking Impairment Question-
naire”9-11 (WIQ) and by the recently proposed “Estimated
Ambulatory Capacity by History-Questionnaire”16 (EACH-Q)
with treadmill measurement. Analyses were performed be-
fore and after correction of questionnaire scores by a coef-
ficient issued from the self-reported estimation of their
usual walking speed by the patients. Patients that were
referred twice during the study period were only included
at their first visit. Patient’s characteristics, medical history,
and medications were retrieved from patients’ files and
completed during the visit if necessary. The study was
submitted to the ethics committee and conforms to the
Helsinki Declaration, the study design and study recording
is accessible on the National Institute of Health Web site
under reference NCT01114178. A signed informed con-
sent to participate in the study was obtained from all
patients.
Diagnosis of PAOD. The evidence of PAOD was
based on the presence of at least one of the following
criteria at the date of inclusion:
● Ankle brachial index (ABI) at rest less than 0.90 on
one or both legs or an ultrasound or radiological
investigation showing stenosis (50% diameter) on
arteries to the lower extremities;
● A history of revascularization (surgery/angioplasty)
for lower extremity arterial disease;
● An abnormal result for transcutaneous oxygen pres-
sure at exercise decrease from rest of oxygen pressure-
index (below negative 15 mm Hg) at least on one side.
This last criterion is of specific interest since many
patients referred to our laboratory report proximal
claudication. Indeed, in this specific situation, ultra-
sound imaging and ABI measurements may frequently
be noncontributive, whereas transcutaneous oxygen
pressure measurement has shown a high diagnostic
performance in this context.17
Filling out of questionnaires. The EACH-Q and
WIQ were self-completed by each patient at arrival and
checked for completion by a technician or a nurse before
the treadmill test. When necessary, missing (no answer to a
question), duplicate (two or more answers to the same
question), or paradoxical answers (eg, higher duration at
higher displacement speed in the new questionnaire) were
discussed with the patient and corrected as previously re-
ported.16 The EACH-Q16 was used as a locally developed
questionnaire assumed to account for usual walking speed,
whereas the WIQ was used as one of the most widely used
available questionnaires from the literature. In brief, the
EACH-Q16 is a four-item questionnaire that estimates the
maximal time (choice of one among eight possible answers)
that can be attained easily without stopping while perform-
ing a displacement at four different paces ranging from slow
walking to running. The WIQ9,11,16,18 is a 14-item ques-
tionnaire divided into three subscales. For each item, the
patient is asked to estimate the degree of difficulty to
perform a defined task (choice of one among five possible Tnswers). The first seven items refer to different distances at
normal speed (WIQ-Distance subscale), the following
our items refer to different displacement speeds for a
efined distance (WIQ-speed subscale), and the last three
tems refer to different number of stairs (WIQ-stair sub-
cale). Complete English translations of the two question-
aires used for this study are available in our previous
ublications.16,18
Self-reported usual walking speed. In addition to
he WIQ and EACH-Q, patients were submitted the fol-
owing question at admission: “Compared to the usual
alking speed of your relatives, friends, or people of your
ge, do you think that you usually walk . . .” (Tick only one
ox).
Much slower □
Moderately slower □
At the same speed □
Moderately faster □
Much faster □
Scoring of the questionnaires. Scoring the WIQ and
f the EACH-Q were performed as previously re-
orted,9,11,16,18 and both scorings resulted in scores rang-
ng from 0 to 100. For the usual-speed question, each
nswer was attributed a coefficient from 1 point for “much
lower,” 2 points for “slightly slower,” and up to 5 points
or “much faster.” Corrected scores were calculated for
oth the WIQ (WIQc) and the EACH-Q (EACH-Qc) by
ultiplying the original scores by the coefficient observed
n the usual-speed answer and dividing the result by 5.
hus, the final WIQc and EACH-Qc scores are still ex-
ressed on scales ranging from 0 to 100. For example, a
atient with a WIQ score of 63 and reports to walk mod-
rately slower than other people will have a WIQc result of
5.2 ( 63  2/5).
Measurement of walking speed. Walking speed was
easured, blinded to the results of questionnaires, by the time
in seconds with one decimal precision) needed to walk 10
eters in the corridor between the waiting room and the
oom where the treadmill tests were performed. The two
ooms are separated by approximately 20 meters. Patients
ere not aware that the technician accompanying them re-
orded their speed between two thin lines drawn on the floor
nd attention was paid by the technician not to precede the
atient to avoid influencing his/her usual walking speed.
Walking capacity on treadmill. The treadmill test
as done blinded to the results of the questionnaires after a
inimum of 15 minutes at rest in the exercise room. Before
he test, patients were informed that the test could be
topped at any time when their symptoms forced them to
top (and not when claudication first occurs). Initial slope
as 10%. Speed was increased from 0 to 3.2 km/hour
ithin 1 minute to allow for the patient’s adaptation to
readmill walking and then stabilized until minute 15.19 It
as previously shown that approximately 15% of the pa-
ients with claudication undergoing a 15-minute constant
oad (3.2 km/hour 10% slope) test did not have to stop.
hen, in order to have all patients being limited on the
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November 20111362 Mahe et altreadmill, at minute 15 of the constant-load test, slope and
speed were progressively increased by steps of 1 minute.
The increment was done in such a way that every 3 minutes,
the slope and speed corresponded to a slope and speed of a
“Bruce” protocol (Table). The purpose here was to im-
prove tolerance of step changes of the Bruce protocol in the
elderly population studied. For all tests, we recorded the
maximal walking time (MWT) performed on a treadmill.
Calculation of the number of patients and statistical
analysis. Results are presented as mean (SD) or median
(25-75 centiles) according to distribution. We estimated that
the correlation coefficient rWIQ-MWT between the noncor-
rected WIQ and MWT would be 0.52,7-13 that correcting the
score with the usual-speed question would increase the corre-
lation coefficient rWIQc-MWT between the corrected WIQ and
MWT to 0.65, and that the correlation coefficient rWIQ-WIQc
between the noncorrected WIQ and the corrected WIQ
would be 0.67. Using these estimations and the method
developed by Meng et al,20 we calculated that 310 patients
were needed to obtain a 95% power with a type I error rate of
0.05 for the comparison of the two coefficient correlations
rWIQ-MWT and rWIQc-MWT. Statistical analyses were per-
formed with SPSS version 15.0. A two-tailedP .05 was used
to indicate statistical significance for all tests.
RESULTS
Three hundred seventeen consecutive different patients
were selected to participate. Seven patients were not in-
cluded, among which five patients refused to participate
and two patients were unable to sign the informed consent
Table. Comparison of the protocol used in the present
study with the Bruce protocol
Bruce protocol Study protocol
Time (minutes) km/hour % Time (minutes) km/hour %
3 2.7 10
15 3.2 10
16 3.7 11
6 4.0 12 17 4.0 12
18 4.8 12
19 5.1 13
9 5.5 14 20 5.5 14
21 6.1 14
22 6.3 15
12 6.8 16 23 6.8 16
24 7.3 16
25 7.6 17
15 8.0 18 26 8.0 18
27 8.5 18
28 8.7 19
18 8.9 20 29 8.9 20
30 9.4 20
31 9.5 21
21 9.6 22 32 9.6 22
33 10.2 22
34 10.3 23
24 10.5 24 35 10.5 24due to low intellectual or educational level. mPopulation studied. The 310 studied patients were
48 men, 62 women, 170 (8) cm height, body weight 76.8
g (14.8), and 62.7 years old (11.3). Risk factors included
iabetes (n  71), active or former smoking (n  250),
ypertension (n 57), and dyslipidemia (n 115). Of the
10 patients, 253 (81.6%) were proved to have PAOD
ased on either ABI0.9 or a positive imaging (n 199),
history of surgery or angioplasty (n  101), or positive
ranscutaneous oxygen tension recording (n  216).
mong non-PAOD comorbid conditions that may alter
alking capacity, 45 patients had a history of coronary or
alvular heart disease, 10 patients have had a stroke, 48
atients had been investigated or treated for osteoarthritis
r lumbar spine stenosis, and eight patients were known to
ave chronic pulmonary disease. On the average, patients
ere symptomatic for more than 2 years when referred to
he laboratory; median 1 year (3 months-3 years). Of the
10 patients, 21 received no medication at all or were
nable to indicate their medication, and no indication for
edication was available in the patient’s file. Of treated
atients, 241 (77.7%) received antiplatelet drugs or antico-
gulants, 205 (66.1%) received cholesterol-lowering
gents, 193 (62.3%) received antihypertensive drugs, 63
20.3%) received antidiabetic drugs, 10 (3.2%) received
entoxifylline, and 85 (27.4%) received beta-blockers.
Filling out of the questionnaires. After self-comple-
ion, 150 (48.4%) of the WIQs and 69 (22.3%) of the
ACH-Qs were corrected for one or more errors (P .05).
he additional speed question was correctly completed by
ll but four patients (1.3%). In all four cases, the error was
missing answer and associated with one or more errors in
ne or both of the WIQ and EACH-Q. There was no
uplicate answer to the usual-speed question.
Questionnaire scores. Median scores for the ques-
ionnaires were 40 (24-71) for the WIQ-distance subscale,
3 (18-50) for the WIQ-speed subscale, 42 (25-67) for the
IQ-stair subscale, 41 (26-59) for the average WIQ score,
nd 24 (11-41) for the EACH-Q score. Most patients (n
40; 77.4%) declared to walk slower than their relatives,
riends, or people of their age. Distribution of answers to
he “usual-speed” item is presented in Fig 1.
Measured walking speed. Walking speed was 3.8
0.6) km/hour for the whole population. As shown, the
ean measured speed increased as a function of the increase
n self-reported estimated speed. It was 3.6 (0.6), 3.9 (0.6),
.1 (0.5), 4.4 (0.6), and 4.5 (1.1) km/hour for self-
eported speed being much slower, moderately slower, at
he same speed, moderately faster, and much faster, respec-
ively. The coefficient of correlation between the self-
stimated category and measured walking speed was rela-
ively low (r  .370), although statistically significant, as
hown in Fig 1. Measured walking speed was 3.93 (0.57)
m/hour in patients with a history of surgery or angioplasty
nd was 3.79 (0.63) km/hour in patients reporting no
rior vascular procedure (P  .062). Measured walking
peed was 3.81 (0.64) km/hour in patients with one or
ore suspected or confirmed vascular or nonvascular co-
orbid condition that may impair walking capacity, and
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Volume 54, Number 5 Mahe et al 1363was 3.87 (0.58) km/hour in patients reporting no comor-
bidity (P  .391).
Maximal walking time on treadmill. Most patients
(n  269; 86.8%) were stopped during the constant load
phase of the walking tests. The mean duration of the
incremental phase (past minute 15 of constant-load exer-
cise) for the other 41 patients was 4 minutes, with the
highest MWT being 22 minutes and 15 seconds. Distribu-
tion of MWT in the studied group is presented in Fig 2.
Correlation of maximal walking time with ques-
tionnaires before and after “usual-speed” correction.
Coefficients of correlation of the WIQ subscales, WIQ, and
EACH-Q, with MWT performed on a treadmill, were all
improved by the use of the “usual-speed” question, although
the difference did not reach significance for the overall WIQ
score on a two-tailed statistic test. The “r” values ranged from
0.469 to 0.605 before correction and 0.585 to 0.638 after
correction by usual walking speed as shown in Fig 3. After
correction by the “usual-speed” question, coefficients of cor-
relation were almost similar for the r (r .638) and
Fig 1. Mean and SE to mean of measured walking speed accord-
ing to the self-reported estimation of usual speed.
Fig 2. Distribution of maximal walking time on treadmill by
intervals of 2 minutes among the 310 studied patients.WIQc-MWT
for the rEACH-Qc-MWT (r .637). sISCUSSION
Estimation of usual walking speed is of interest when
ne aims at estimating walking capacity of patients, specif-
cally in patients with suspected PAOD.9-12 The walking
peed may vary from one patient to another,21,22 and
symptomatic patients with peripheral arterial disease have
lower usual walking speeds than patients with PAOD with
laudication.22 Nevertheless, it seems that for one patient,
he variability of walking speed is small both in test-retest
ecordings23,24 and within a prolonged 1-hour stroll.25
mazingly, many studies have focused on the measurement
f walking speed over various test distances,21,26-30 but to
he best of our knowledge, only one large-scale study has
ver estimated the usual walking pace with a question-
aire.26 Adding one question to the WIQ and EACH-Q
hanges the initial 70 boxes to 75 boxes and 32 to 37
oxes, respectively, but does not seem to result in more
issing values. Indeed, only four of 310 patients could not
omplete the “usual-speed” question and all had missing
nswers to the other questionnaires.
The WIQ estimates the degree of difficulty of the
atient to perform different tasks (different walking dis-
ances, different speeds for a defined walking distance, or
ifferent number of stair flights). Then, the WIQ is assumed
o be sensitive to usual speed. Indeed, it does correlate to the
4-meter usual pace” speed through its speed subscale.10 It is
orth noting that, by construction, the “weight” of speed
ubscale over the final WIQ score is assumed to be one-third,
ecause the final WIQ score is the mean of the three sub-
ig 3. Correlations of the Walking Impairment Questionnaire-
istance (WIQd), WIQspeed (WIQs) and WIQstairs subscales,
verall WIQ, and Estimated Ambulatory Capacity by History-
uestionnaire (EACH-Q) to maximal walking time on a treadmill
efore (noncorrected) and after (speed corrected) correction by
he “usual-speed” answer.cores. In fact, the “weight” of speed in the WIQ score is
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November 20111364 Mahe et alvariable and ranges from zero to 50%. When only two sub-
scales are available, the “weight” of speed over the final score
may be zero (if the missing score is that of the speed subscale)
or 50% (if the missing scale is not the speed scale).6,10 Finally,
the WIQ speed subscales focus on the difficulty to perform a
defined walking distance but in fact, not on the usual walking
pace of the patient itself. Then we expected that accounting
for usual walking pace as done in the present study would have
improved the correlation with treadmill results. Using a two-
tailed statistical approach, we failed to confirm this, al-
though all subscale scores were significantly improved. This
might partly be because the coefficient observed for uncor-
rected overall WIQ results was unexpectedly already in the
high range of the results previously reported in the litera-
ture.10,12 As a result of this high coefficient and in perspec-
tive of the “P” value attained on the two-tailed statistical
test, it is likely that a study including more patients would
statistically confirm our initial hypothesis. Of interest and
quite unexpectedly, the correction of the EACH-Q did
result in a significant improvement of the correlation of
the questionnaire to treadmill-measured capacity. The
EACH-Q was designed to estimate the maximal ambula-
tory time for different ambulatory speeds. Then, the
EACH-Q was expected to be sensitive to the usual walking
pace and was less likely to benefit a correction through the
additional “usual-speed” question. The fact that correction
of the EACH-Q through the usual-speed question im-
proved the correlation with the treadmill result might
suggest that the coefficients that were arbitrarily chosen for
the scoring of the EACH-Q were inadequate to satisfacto-
rily account for the effect of speed over walking capacity.
An original point of the present study was the use of a
treadmill test combining a constant load and an incremen-
tal procedure. Constant load tests seem to better fit to a
usual walk but do not allow all patients to be symptom-
limited, whereas incremental procedures may result in pa-
tients being stopped for cardiorespiratory reasons and not
by claudication. Further, incremental tests do not repro-
duce usual walking. In the present study, combining the
two approaches allowed 85% of patients to reach their limit
over the constant load period and the remaining 15% to
reach their limit during the incremental load period. We
found a similar proportion of patients that had test duration
in excess of 15 minutes in previous reports.31 Future works
must be done to confirm the results presented here with
other exercise test protocols.
Among limitations of the present study are specificities
of our population, with most of the studied patients having
PAOD, with a high proportion of men and of patients with
proximal claudication. These proportions are consistent
with those observed in our previous articles but may limit
the use of these results in the general population. It should
be noted that in this prospective study, the number of
patients that refused to participate was very low (2%).
Then, the studied population is assumed to represent the
patients that attend our laboratory for the estimation of
vascular-type claudication. Second, we did not study the
correlation of the speed-item answer with other measuresf walking speed as could be attained with a 4-meter
alking velocity test29,32 or with the GPS technique.13,25
uch analyses have to be performed and might provide
esults slightly different from those observed over 10 me-
ers. Third, we did not account for the patient’s level of
ducation or for socioeconomic issues. We think that this
ould have been of little interest because we had very few
rrors or missing answers in the usual-speed question. Last,
alidation in other causes of walking limitation (hip or knee
rthritis, lumbar spine stenosis) is to be done.
In practice, most results from the literature show a rela-
ively low correlation between the self-reported estimation of
alking capacity by questionnaires and the objective measure-
ents, whatever the objective tests are.9-12 Nevertheless,
uestionnaires are not aimed at replacing objective recordings
xcept in epidemiologic studies or if estimation of walking is to
e performed through a telephone interview.6,33 Objective
ests (treadmill, pedometers, satellite positioning, 6-minute
alking test) also have their own limits, and the results of these
objective” tests may depend on the procedure used. Even
hen objective measurements are performed, questionnaires
re useful and should be used as standard tools to estimate the
atient’s perception of walking disability. Usual walking speed
s certainly one major candidate to explain discrepancies be-
ween objective and subjective results. What is shown here is
hat self-reported estimation of usual walking pace is feasible,
s easily done by the patients, and results in very few missing
nswers.
In conclusion, correcting the self-reported estimation
f walking capacity by a self-reported estimation of usual
alking pace: (1) significantly improves the correlation of
ll the WIQ subscales and the EACH-Q scores with tread-
ill measurements and (2) tends to improve the correlation
or the overall WIQ score with the objective measurement
f capacity on the treadmill. Corrected scores for both WIQ
nd EACH-Q reach high coefficients of correlation with
alking time on a treadmill that were rarely observed in any
revious experiments, among patients with claudication,
hus confirming the interest of speed estimation in patients
ith PAOD and claudication.
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